Millennium Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,400
Closed -$1.62M 6461
2025
Q3
$1.62M Sell
14,400
-12,700
-47% -$1.49M ﹤0.01% 4238
2025
Q2
$3.63M Sell
27,100
-7,700
-22% -$845K ﹤0.01% 3312
2025
Q1
$2.34M Buy
34,800
+26,900
+341% +$1.85M ﹤0.01% 3636
2024
Q4
$493K Buy
7,900
+1,000
+14% +$93.1K ﹤0.01% 4764
2024
Q3
$1.08M Hold
6,900
﹤0.01% 4206
2024
Q2
$1.04M Sell
6,900
-103,500
-94% -$12.4M ﹤0.01% 4087
2024
Q1
$8.16M Buy
+110,400
New +$9.1M ﹤0.01% 2385
2023
Q4
Sell
-61,200
Closed -$3.35M 6536
2023
Q3
$3.35M Buy
+61,200
New +$4.41M ﹤0.01% 3095

Other funds holding TMDX

Millennium Management's TMDX Position: Q1 2026 in Review

Millennium Management increased its Transmedics (TMDX) stake by 105% in Q1 2026, buying an estimated $20.5M and bringing the position to 306,080 shares worth $30.4M. The position accounts for 0.01% of the portfolio, ranked #1220.

Millennium Management first reported a position in TMDX in Q2 2019 and has held it in 18 quarters since. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Millennium Management held 306,080 shares of Transmedics worth $30.4M as of Q1 2026.
  • Millennium Management bought 157,049 Transmedics shares in Q1 2026, an estimated $20.5M.
  • Transmedics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1220 holding.
  • Millennium Management first reported a position in Transmedics in Q2 2019 and has held it in 18 quarters since.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.